1177.HK vs. 1099.HK

Last updated Apr 3, 2026

Compare and contrast key facts about Sino Biopharmaceutical Ltd (1177.HK) and Sinopharm Group Co Ltd (1099.HK).

Performance

1177.HK vs. 1099.HK - Performance Comparison

The chart below illustrates the hypothetical performance of a HK$10,000 investment in Sino Biopharmaceutical Ltd (1177.HK) and Sinopharm Group Co Ltd (1099.HK). The values are adjusted to include any dividend payments, if applicable.

1177.HK vs. 1099.HK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
1177.HK Sino Biopharmaceutical Ltd	2.43%	95.80%	-5.90%	-22.28%	-14.19%	-26.80%	-30.77%	112.18%	-62.62%	154.86%
1099.HK Sinopharm Group Co Ltd	7.61%	-5.08%	8.88%	6.78%	22.50%	-7.07%	-31.41%	-11.36%	-0.45%	7.52%

Returns By Period

In the year-to-date period, 1177.HK achieves a 2.43% return, which is significantly lower than 1099.HK's 7.61% return. Over the past 10 years, 1177.HK has outperformed 1099.HK with an annualized return of 2.24%, while 1099.HK has yielded a comparatively lower -1.73% annualized return.

1177.HK

• 1D: -0.47%
• 1M: 10.86%
• YTD: 2.43%
• 6M: -24.19%
• 1Y: 62.47%
• 3Y*: 16.86%
• 5Y*: -2.29%
• 10Y*: 2.24%

1099.HK

• 1D: 2.05%
• 1M: -0.29%
• YTD: 7.61%
• 6M: 11.81%
• 1Y: 18.25%
• 3Y*: -0.68%
• 5Y*: 5.62%
• 10Y*: -1.73%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

1177.HK vs. 1099.HK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

1177.HK

1177.HK Risk / Return Rank: 76
1177.HK Sharpe Ratio Rank: 80
1177.HK Sortino Ratio Rank: 77
1177.HK Omega Ratio Rank: 75
1177.HK Calmar Ratio Rank: 77
1177.HK Martin Ratio Rank: 72

1099.HK

1099.HK Risk / Return Rank: 67
1099.HK Sharpe Ratio Rank: 70
1099.HK Sortino Ratio Rank: 61
1099.HK Omega Ratio Rank: 61
1099.HK Calmar Ratio Rank: 72
1099.HK Martin Ratio Rank: 71

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

1177.HK vs. 1099.HK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sino Biopharmaceutical Ltd (1177.HK) and Sinopharm Group Co Ltd (1099.HK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	1177.HK	1099.HK	Difference
Sharpe ratio Return per unit of total volatility	1.34	0.88	+0.46
Sortino ratio Return per unit of downside risk	2.00	1.28	+0.72
Omega ratio Gain probability vs. loss probability	1.26	1.18	+0.08
Calmar ratio Return relative to maximum drawdown	2.21	1.78	+0.42
Martin ratio Return relative to average drawdown	4.31	4.11	+0.21
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

1177.HK vs. 1099.HK - Sharpe Ratio Comparison

The current 1177.HK Sharpe Ratio is 1.34, which is higher than the 1099.HK Sharpe Ratio of 0.88. The chart below compares the historical Sharpe Ratios of 1177.HK and 1099.HK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	1177.HK	1099.HK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.34	0.88	+0.46
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.06	0.18	-0.24
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.05	-0.06	+0.11
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	0.09	+0.07

Correlation

The correlation between 1177.HK and 1099.HK is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

1177.HK vs. 1099.HK - Dividend Comparison

1177.HK's dividend yield for the trailing twelve months is around 1.42%, less than 1099.HK's 3.53% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
1177.HK Sino Biopharmaceutical Ltd	1.42%	1.46%	1.88%	2.31%	2.19%	0.73%	0.71%	0.37%	0.90%	0.22%	0.49%	0.25%
1099.HK Sinopharm Group Co Ltd	3.53%	3.80%	4.49%	4.40%	4.40%	4.95%	3.46%	2.36%	2.09%	1.69%	1.51%	1.26%

Drawdowns

1177.HK vs. 1099.HK - Drawdown Comparison

The maximum 1177.HK drawdown since its inception was -87.72%, which is greater than 1099.HK's maximum drawdown of -64.96%. Use the drawdown chart below to compare losses from any high point for 1177.HK and 1099.HK.

Drawdown Indicators

	1177.HK	1099.HK	Difference
Max Drawdown Largest peak-to-trough decline	-87.72%	-64.96%	-22.76%
Max Drawdown (1Y) Largest decline over 1 year	-36.63%	-10.38%	-26.25%
Max Drawdown (5Y) Largest decline over 5 years	-72.72%	-43.19%	-29.53%
Max Drawdown (10Y) Largest decline over 10 years	-87.72%	-64.96%	-22.76%
Current Drawdown Current decline from peak	-65.63%	-37.79%	-27.84%
Average Drawdown Average peak-to-trough decline	-45.27%	-34.04%	-11.23%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.73%	4.51%	+14.22%

Volatility

1177.HK vs. 1099.HK - Volatility Comparison

Sino Biopharmaceutical Ltd (1177.HK) has a higher volatility of 12.46% compared to Sinopharm Group Co Ltd (1099.HK) at 6.47%. This indicates that 1177.HK's price experiences larger fluctuations and is considered to be riskier than 1099.HK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	1177.HK	1099.HK	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.46%	6.47%	+5.99%
Volatility (6M) Calculated over the trailing 6-month period	27.23%	14.50%	+12.73%
Volatility (1Y) Calculated over the trailing 1-year period	48.11%	21.24%	+26.87%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	40.82%	31.51%	+9.31%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	44.61%	30.74%	+13.87%

Financials